<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref045">
 <label>45</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Budigi</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Ong</surname>
   <given-names>EZ</given-names>
  </name>, 
  <name>
   <surname>Robinson</surname>
   <given-names>LN</given-names>
  </name>, 
  <name>
   <surname>Ong</surname>
   <given-names>LC</given-names>
  </name>, 
  <name>
   <surname>Rowley</surname>
   <given-names>KJ</given-names>
  </name>, 
  <name>
   <surname>Winnett</surname>
   <given-names>A</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein</article-title>. 
  <source>PLoS Negl Trop Dis</source>. 
  <year>2018</year>;
  <volume>12</volume>(
  <issue>2</issue>):
  <fpage>e0006209</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pntd.0006209</pub-id>
  <?supplied-pmid 29425203?>
  <pub-id pub-id-type="pmid">29425203</pub-id>
 </mixed-citation>
</ref>
